Search Results - "Bo, Yunhai"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    An intergated serum and urinary metabonomic research based on UPLC-MS and therapeutic effects of Gushudan on prednisolone-induced osteoporosis rats by Huang, Yue, Bo, Yunhai, Wu, Xiao, Wang, Qiuyi, Qin, Feng, Zhao, Longshan, Xiong, Zhili

    “…•An intergated serum and urinary metabonomic to study osteoporosis has been proposed.•The mechanism of Gushudan relies on regulating multiple metabolic…”
    Get full text
    Journal Article
  3. 3

    A validated UHPLC‐MS/MS method for determination of TQ‐B3203 in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor by Yang, Fen, Zhou, Jun, Bo, Yunhai, Yin, Han, Liu, Xiao Hong, Li, Jian

    Published in Journal of separation science (01-03-2021)
    “…TQ‐B3203 is a new topoisomerase I inhibitor derived from camptothecin. In this paper, a simple and reliable ultra high‐performance liquid chromatography‐tandem…”
    Get full text
    Journal Article
  4. 4

    Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors by Li, Xiaoqing, Bo, Yunhai, Yin, Han, Liu, Xiaohong, Li, Xu, Yang, Fen

    Published in Frontiers in pharmacology (16-01-2023)
    “…TQ-B3203 is a novel topoisomerase I inhibitor currently in development for the treatment of advanced solid tumors. Great differences in pharmacokinetic…”
    Get full text
    Journal Article
  5. 5

    Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors by Li, Xiaoqing, Bo, Yunhai, Zeng, Qingping, Diao, Lei, Greene, Stephanie, Patterson, John, Liu, Lu, Yang, Fen

    Published in Frontiers in pharmacology (04-03-2024)
    “…ORIN1001, a first-in-class oral IRE1-α endoribonuclease inhibitor to block the activation of XBP1, is currently in clinical development for inhibiting tumor…”
    Get full text
    Journal Article
  6. 6

    Population Pharmacokinetic Modeling and Simulation of TQ-B3101 to Inform Dosing in Pediatric Patients With Solid Tumors by Yang, Fen, Wu, Huali, Bo, Yunhai, Lu, Ye, Pan, Hong, Li, Su, Lu, Qin, Xie, Simin, Liao, Harry, Wang, Bing

    Published in Frontiers in pharmacology (18-01-2022)
    “…TQ-B3101 is a novel kinase inhibitor currently in development for the treatment of advanced malignant solid tumor and relapsed or refractory ALK-positive…”
    Get full text
    Journal Article
  7. 7

    Simultaneous Determination of D and L Enantiomers of 2-Hydroxyglutarate by UHPLC-MS/MS Method in Human Biological Fluids and its Clinical Application by Li, Xiaoqing, Bo, Yunhai, Le, Le, Yang, Fen

    Published in Journal of chromatographic science (28-03-2024)
    “…2-hydroxyglutarate has limited abundance in normal tissues but a high level under certain pathologic conditions. To clarify the diagnostic value of two chiral…”
    Get full text
    Journal Article
  8. 8

    Plasma metabolomics combined with mass spectrometry imaging reveals crosstalk between tumor and plasma in gastric cancer genesis and metastasis by Chen, Yanhua, Ding, Xian, Zhou, Jun, Wang, Zhaoying, Bo, Yunhai, Hu, Ying, Zang, Qingce, Xu, Jing, Zhang, Ruiping, He, Jiuming, Yang, Fen, Abliz, Zeper

    Published in Chinese chemical letters (01-01-2025)
    “…Gastric Carcinoma (GC) is a highly fatal malignant tumor with a poor prognosis. Its elevated mortality rates are primarily due to its proclivity for late-stage…”
    Get full text
    Journal Article
  9. 9

    Serum metabonomics study of anti-depressive effect of Xiao-Chai-Hu-Tang on rat model of chronic unpredictable mild stress by Xiong, Zhili, Yang, Jie, Huang, Yue, Zhang, Kuo, Bo, Yunhai, Lu, Xiumei, Su, Guangyue, Ma, Jie, Yang, Jingyu, Zhao, Longshan, Wu, Chunfu

    “…•The potential biomarkers in a chronic unpredictable mild stress model were identified.•Nine metabolites were characterized as potential biomarkers.•The…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Simultaneous determination of epalrestat and puerarin in rat plasma by UHPLC–MS/MS: Application to their pharmacokinetic interaction study by Sun, Hong, Bo, Yunhai, Zhang, Mingjie, Wu, Xiao, Zhou, Mingyang, Zhao, Longshan, Xiong, Zhili

    Published in Biomedical chromatography (01-04-2017)
    “…In the present study, a simple, rapid and reliable ultrahigh‐performance liquid chromatography–tandem mass spectrometric (UHPLC–MS/MS) method was developed and…”
    Get full text
    Journal Article